HORIZON Side Effects

6432065-X | Asthma, Glossoptosis, Respiratory Depression
on Oct 28, 2009 Female patient from JAPAN , weighting 20.50 lb, was diagnosed with convulsion, otitis media, dehydration, pneumonia (What is pneumonia?), upper respiratory tract inflammation and was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), glossoptosis, respiratory depression. Horizon dosage: 5 Mg, Uid/qd. During the same period patient was treated with DORMICUM (INJ) (3 Mg, Uid/qd) (View Dormicum (inj) Review and Dormicum (inj) Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), SOLDEM (View Soldem Review and Soldem Label ), ZITHROMAX (Route: Per Oral, Uid/qd) (View Zithromax Review and Zithromax Label ), ASVERIN (View Asverin Review and Asverin Label ), TELGIN G (View Telgin-g Review and Telgin-g Label ), HOKUNALIN (Form: Tape) (View Hokunalin Review and Hokunalin Label ), DIAPP (View Diapp Review and Diapp Label ). Patient was hospitalized.

6410313-X | Asthma
Patient was taking Horizon (View Usage). Patient had the following side effects: asthma (What is asthma?) on Oct 14, 2009 from JAPAN Additional patient health information: Female patient , weighting 20.50 lb, was diagnosed with convulsion and. Horizon dosage: 5 Mg, Uid/qd. During the same period patient was treated with DORMICUM (INJ) (3 Mg, Uid/qd) (View Dormicum (inj) Review and Dormicum (inj) Label ), MUCODYNE (Dry Syrup) (View Mucodyne Review and Mucodyne Label ), HOKUNALIN (Form: Tape) (View Hokunalin Review and Hokunalin Label ), DIAPP (View Diapp Review and Diapp Label ). Patient was hospitalized.

5697920-7 | Injection Site Pain, Vascular Injury
Adverse event was reported on Mar 27, 2008 by a Female patient taking Horizon (View Usage) (Dosage: ) . Location: JAPAN , 52 years of age, After Horizon was administered, patient had the following side effects: injection site pain, vascular injury. During the same period patient was treated with LACTEC (View Lactec Review and Lactec Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), HERBAL EXTRACTS NOS (Daikenchu-to/chinese Herbal Medicine.) (View Herbal Extracts Nos Review and Herbal Extracts Nos Label ).

5684535-X | Erythema, Feeling Hot, Hypoaesthesia
on Mar 18, 2008 Female patient from JAPAN , 56 years of age, was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, feeling hot, hypoaesthesia. Horizon dosage: .


5655515-5 | Cognitive Disorder
on Feb 25, 2008 Male patient from JAPAN , 35 years of age, was diagnosed with narcolepsy and was treated with Horizon (View Usage). Patient had the following side effects: cognitive disorder. Horizon dosage: Indication: Narcolepsy, Depressed State.. During the same period patient was treated with RITALIN (View Ritalin Review and Ritalin Label ), PEMOLINE (View Pemoline Review and Pemoline Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), AKINETON (View Akineton Review and Akineton Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), INSULIN (View Insulin Review and Insulin Label ).

5578060-4 | Thrombophlebitis
Patient was taking Horizon (View Usage). After Horizon was administered, patient had the following side effects: thrombophlebitis on Dec 19, 2007 from JAPAN Additional patient health information: Male patient , 58 years of age, . Horizon dosage: . Patient was hospitalized.

5578058-6 | Amnesia
Adverse event was reported on Dec 18, 2007 by a Female patient taking Horizon (View Usage) (Dosage: The Patient Had Received 5 Mg At 1ml Solution) was diagnosed with endoscopy (What is endoscopy?) and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: amnesia. During the same period patient was treated with PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ).

5571464-5 | Thrombophlebitis
on Dec 14, 2007 Male patient from JAPAN , 58 years of age, was treated with Horizon (View Usage). Patient had the following side effects: thrombophlebitis. Horizon dosage: . Patient was hospitalized.

5553850-2 | Venous Thrombosis Limb
on Dec 03, 2007 Male patient from JAPAN , 58 years of age, was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: venous thrombosis limb. Horizon dosage: . Patient was hospitalized.

5541934-4 | Diarrhoea, Hepatic Function Abnormal, Nutritional Condition Abnormal, Pancreatitis, Pneumonia
Patient was taking Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hepatic function abnormal, nutritional condition abnormal, pancreatitis, pneumonia (What is pneumonia?) on Nov 28, 2007 from JAPAN Additional patient health information: Female patient , 61 years of age, was diagnosed with depression (What is depression?) and. Horizon dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), PAXIL (View Paxil Review and Paxil Label ), AMOBAN (View Amoban Review and Amoban Label ). Patient was hospitalized.

5537671-2 | Diarrhoea, Hepatic Function Abnormal, Nutritional Condition Abnormal, Pancreatitis
Adverse event was reported on Nov 28, 2007 by a Female patient taking Horizon (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: JAPAN , 61 years of age, Patient had the following side effects: diarrhoea, hepatic function abnormal, nutritional condition abnormal, pancreatitis. During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), PAXIL (View Paxil Review and Paxil Label ), AMOBAN (View Amoban Review and Amoban Label ). Patient was hospitalized.

5531867-1 | Cardiac Arrest, Depressed Level Of Consciousness, Hepatitis Fulminant
on Nov 21, 2007 Female patient from JAPAN , 65 years of age, was diagnosed with subcutaneous abscess, hypercholesterolaemia, hypertension and was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), depressed level of consciousness, hepatitis fulminant. Horizon dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYTOTEC (View Cytotec Review and Cytotec Label ), LOCHOL (View Lochol Review and Lochol Label ), BLOPRESS (View Blopress Review and Blopress Label ), CALBLOCK (View Calblock Review and Calblock Label ), FOY (View Foy Review and Foy Label ). Patient was hospitalized.

5524679-6 | Blood Pressure Decreased, Cardiac Arrest, Condition Aggravated, Convulsion, Glossoptosis, Hepatitis Fulminant
on Nov 08, 2007 Female patient from JAPAN , 65 years of age, was diagnosed with subcutaneous abscess, hypercholesterolaemia, hypertension and was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), condition aggravated, convulsion, glossoptosis, hepatitis fulminant. Horizon dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYTOTEC (View Cytotec Review and Cytotec Label ), LOCHOL (View Lochol Review and Lochol Label ), BLOPRESS (View Blopress Review and Blopress Label ), CALBLOCK (View Calblock Review and Calblock Label ), FOY (View Foy Review and Foy Label ). Patient was hospitalized.

5523751-4 | Blood Pressure Decreased, Cardiac Arrest, Cerebral Infarction, Convulsion, Disseminated Intravascular Coagulation, Glossoptosis, Heart Rate Increased, Hepatitis Fulminant, Platelet Count Decreased
Patient was taking Horizon (View Usage). Patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), cerebral infarction, convulsion, disseminated intravascular coagulation, glossoptosis, heart rate increased, hepatitis fulminant, platelet count decreased on Nov 08, 2007 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with subcutaneous abscess, hypercholesterolaemia, hypertension and. Horizon dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYTOTEC (View Cytotec Review and Cytotec Label ), LOCHOL (View Lochol Review and Lochol Label ), BLOPRESS (View Blopress Review and Blopress Label ), CALBLOCK (View Calblock Review and Calblock Label ), FOY (View Foy Review and Foy Label ).

5520983-6 | Anterograde Amnesia
Adverse event was reported on Nov 08, 2007 by a Female patient taking Horizon (View Usage) (Dosage: The Patient Had Received 5 Mg Once Year For Last 3 Years) was diagnosed with endoscopy (What is endoscopy?) and. Location: JAPAN , 59 years of age, After Horizon was administered, patient had the following side effects: anterograde amnesia. During the same period patient was treated with PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ).

5514181-X | Diarrhoea, Liver Disorder, Nutritional Condition Abnormal, Pancreatitis
on Nov 01, 2007 Female patient from JAPAN , 61 years of age, was diagnosed with depression (What is depression?) and was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, liver disorder, nutritional condition abnormal, pancreatitis. Horizon dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), PAXIL (View Paxil Review and Paxil Label ), AMOBAN (View Amoban Review and Amoban Label ).

5507981-3 | Overdose, Posture Abnormal, Renal Failure Acute
on Oct 25, 2007 Male patient from JAPAN , 39 years of age, was treated with Horizon (View Usage). Patient had the following side effects: overdose, posture abnormal, renal failure acute. Horizon dosage: Overdose.

5497074-6 | Compartment Syndrome, Overdose, Renal Failure Acute
Patient was taking Horizon (View Usage). After Horizon was administered, patient had the following side effects: compartment syndrome, overdose, renal failure acute on Oct 15, 2007 from JAPAN Additional patient health information: Male patient , 39 years of age, . Horizon dosage: Overdose.

5334930-3 | Thrombophlebitis
Adverse event was reported on May 29, 2006 by a Female patient taking Horizon (View Usage) (Dosage: ) was diagnosed with anaesthesia, prophylaxis of abortion, prophylaxis against gastrointestinal ulcer and. Location: JAPAN , 30 years of age, Patient experienced the following unwanted or unexpected effects: thrombophlebitis. During the same period patient was treated with PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), METENARIN (View Metenarin Review and Metenarin Label ), VEEN F (View Veen-f Review and Veen-f Label ), ZANTAC (View Zantac Review and Zantac Label ).

5234389-0 | Feeling Abnormal, Respiratory Depression
on Jan 30, 2007 Female patient from JAPAN , 31 years of age, was diagnosed with sedation and was treated with Horizon (View Usage). Patient had the following side effects: feeling abnormal, respiratory depression. Horizon dosage: . During the same period patient was treated with PHYSIOSOL (View Physiosol Review and Physiosol Label ).

5221859-4 | Deep Vein Thrombosis, Pulmonary Embolism
on Jan 18, 2007 Male patient from JAPAN , 72 years of age, was diagnosed with sedation, tetanus (What is tetanus?), angina pectoris, prophylaxis and was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Horizon dosage: Daily Dose: 15 Mg Divided Into 6 Doses.. During the same period patient was treated with PENICILLIN G (View Penicillin G Review and Penicillin G Label ), ADSORBED TETANUS TOXOID (View Adsorbed Tetanus Toxoid Review and Adsorbed Tetanus Toxoid Label ), ANTITETANUS IMMUNOGLOBULIN INJECTION (View Antitetanus Immunoglobulin Injection Review and Antitetanus Immunoglobulin Injection Label ), ITOROL (View Itorol Review and Itorol Label ), GASTER (View Gaster Review and Gaster Label ). Patient was hospitalized.

5207132-9 | Deep Vein Thrombosis, Pulmonary Embolism
Patient was taking Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) on Dec 30, 2006 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with sedation, tetanus (What is tetanus?) and. Horizon dosage: Daily Dose: 15 Mg Divided Into 6 Doses.. During the same period patient was treated with PENICILLIN G (View Penicillin G Review and Penicillin G Label ), ADSORBED TETANUS TOXOID (View Adsorbed Tetanus Toxoid Review and Adsorbed Tetanus Toxoid Label ), ANTITETANUS IMMUNOGLOBULIN INJECTION (View Antitetanus Immunoglobulin Injection Review and Antitetanus Immunoglobulin Injection Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), GASTER (View Gaster Review and Gaster Label ). Patient was hospitalized.

5176025-8 | Convulsion
Adverse event was reported on Dec 07, 2006 by a Male patient taking Horizon (View Usage) (Dosage: ) . Location: JAPAN , 44 years of age, Patient had the following side effects: convulsion.

5164463-9 | Deep Vein Thrombosis, Pulmonary Embolism
on Nov 27, 2006 Male patient from JAPAN , 72 years of age, was diagnosed with sedation, tetanus (What is tetanus?) and was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Horizon dosage: . During the same period patient was treated with PENICILLIN (View Penicillin Review and Penicillin Label ), ADSORBED TETANUS TOXOID (View Adsorbed Tetanus Toxoid Review and Adsorbed Tetanus Toxoid Label ), ANTITETANUS IMMUNOGLOBULIN INJECTION (View Antitetanus Immunoglobulin Injection Review and Antitetanus Immunoglobulin Injection Label ). Patient was hospitalized.

5161398-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
on Nov 27, 2006 Female patient from JAPAN , 64 years of age, was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder. Horizon dosage: . During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), VESICARE (View Vesicare Review and Vesicare Label ), AJMALINE (View Ajmaline Review and Ajmaline Label ). Patient was hospitalized.

5117538-4 | Interstitial Lung Disease, Pulmonary Fibrosis, Stomach Discomfort
Patient was taking Horizon (View Usage). Patient had the following side effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?), stomach discomfort on Jun 29, 2006 from JAPAN Additional patient health information: Male patient , 68 years of age, was diagnosed with insomnia, hyperlipidaemia, arrhythmia (What is arrhythmia?) and. Horizon dosage: Taken When Needed. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), BEPRICOR (View Bepricor Review and Bepricor Label ), BLUEBERRY (View Blueberry Review and Blueberry Label ). Patient was hospitalized.

5104815-6 | Alveolitis, Interstitial Lung Disease, Pneumonitis, Pulmonary Fibrosis, Stomach Discomfort
Adverse event was reported on Jun 29, 2006 by a Male patient taking Horizon (View Usage) (Dosage: Taken When Needed) was diagnosed with insomnia, hyperlipidaemia, arrhythmia (What is arrhythmia?) and. Location: JAPAN , 68 years of age, After Horizon was administered, patient had the following side effects: alveolitis, interstitial lung disease, pneumonitis, pulmonary fibrosis (What is pulmonary fibrosis?), stomach discomfort. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), BEPRICOR (View Bepricor Review and Bepricor Label ). Patient was hospitalized.

5056342-2 | Interstitial Lung Disease, Stomach Discomfort
on Jun 29, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with insomnia, hyperlipidaemia, arrhythmia (What is arrhythmia?) and was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, stomach discomfort. Horizon dosage: Taken When Needed. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), BEPRICOR (View Bepricor Review and Bepricor Label ). Patient was hospitalized.

5045580-0 | Interstitial Lung Disease, Stomach Discomfort
on Jun 29, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with insomnia, hyperlipidaemia, arrhythmia (What is arrhythmia?) and was treated with Horizon (View Usage). Patient had the following side effects: interstitial lung disease, stomach discomfort. Horizon dosage: Taken When Needed. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), BEPRICOR (View Bepricor Review and Bepricor Label ). Patient was hospitalized.

5040558-5 | Lymphadenitis
Patient was taking Horizon (View Usage). After Horizon was administered, patient had the following side effects: lymphadenitis on Jun 19, 2006 from JAPAN Additional patient health information: Female patient , 31 years of age, . Horizon dosage: . During the same period patient was treated with ACCENON (View Accenon Review and Accenon Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), MENDON (View Mendon Review and Mendon Label ), LEUCON (View Leucon Review and Leucon Label ). Patient was hospitalized.

4943300-9 | Hepatic Failure
Adverse event was reported on Mar 03, 2006 by a Male patient taking Horizon (View Usage) (Dosage: ) . Location: JAPAN , 35 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

4943251-X | Hepatic Failure
on Mar 03, 2006 Female patient from JAPAN , 31 years of age, was treated with Horizon (View Usage). Patient had the following side effects: hepatic failure. Horizon dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

4927568-0 | Cardiac Arrest, Cerebral Atrophy, Cerebral Infarction, Depressed Level Of Consciousness, Injury Asphyxiation, Tetanus, Vomiting
on Jan 27, 2006 Male patient from JAPAN , 79 years of age, was diagnosed with convulsion prophylaxis and was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cerebral atrophy, cerebral infarction, depressed level of consciousness, injury asphyxiation, tetanus (What is tetanus?), vomiting. Horizon dosage: Route Reported As Dr.. During the same period patient was treated with LEPETAN (Route Reported As Dr.) (View Lepetan Review and Lepetan Label ). Patient was hospitalized.

4895580-6 | Liver Disorder
Patient was taking Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Dec 28, 2005 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with status epilepticus and. Horizon dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

4860176-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Depressed Level Of Consciousness, Respiratory Failure
Adverse event was reported on Nov 14, 2005 by a Female patient taking Horizon (View Usage) (Dosage: ) was diagnosed with chemical poisoning, miosis, nausea (What is nausea?) and. Location: JAPAN , 67 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, depressed level of consciousness, respiratory failure. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), PRIMPERAN INJ (Indication Reported To Be Nausea And Vomiting.) (View Primperan Inj Review and Primperan Inj Label ). Patient was hospitalized.

4855706-7 | Shock, Small Intestinal Haemorrhage
on Dec 05, 2005 Male patient from JAPAN , 62 years of age, was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: shock, small intestinal haemorrhage. Horizon dosage: . During the same period patient was treated with FAMOTIDINE (Route: Dr.) (View Famotidine Review and Famotidine Label ), ALBUMIN (HUMAN) (Route: Dr.) (View Albumin (human) Review and Albumin (human) Label ). Patient was hospitalized.

4847345-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Respiratory Failure
on Nov 14, 2005 Female patient from JAPAN , 67 years of age, was diagnosed with chemical poisoning, miosis, nausea (What is nausea?) and was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, respiratory failure. Horizon dosage: . During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), PRIMPERAN INJ (Indication Reported To Be Nausea And Vomiting.) (View Primperan Inj Review and Primperan Inj Label ). Patient was hospitalized.

4837971-5 | Depressed Level Of Consciousness, Respiratory Failure
Patient was taking Horizon (View Usage). Patient had the following side effects: depressed level of consciousness, respiratory failure on Nov 14, 2005 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with miosis, nausea (What is nausea?) and. Horizon dosage: . During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ). Patient was hospitalized.

4742579-6 | Blood Pressure Decreased, Device Failure, Dyspnoea, Inadequate Analgesia, Oxygen Saturation Decreased, Procedural Complication, Speech Disorder, Tongue Paralysis
Adverse event was reported on Jun 10, 2005 by a Male patient taking Horizon (View Usage) (Dosage: At 10.30.) was diagnosed with sedation and. Location: JAPAN , 58 years of age, weighting 191.8 lb, After Horizon was administered, patient had the following side effects: blood pressure decreased, device failure, dyspnoea, inadequate analgesia, oxygen saturation decreased, procedural complication, speech disorder, tongue paralysis. During the same period patient was treated with SEVOFLURANE (At 14.55. (0.6 %) Indication Reported As Sedation And Analgesia.) (View Sevoflurane Review and Sevoflurane Label ), DIPRIVAN (At 13.15) (View Diprivan Review and Diprivan Label ), CARBOCAIN (At 14.00 Hours.) (View Carbocain Review and Carbocain Label ), FENTANYL CITRATE (At 13.50.) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ).

4733250-5 | Glycosylated Haemoglobin Increased, Hyperglycaemia, Hyperphagia, Polydipsia, Polyuria, Thirst
on Jul 15, 2005 Female patient from JAPAN , 68 years of age, was diagnosed with diabetes mellitus and was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: glycosylated haemoglobin increased, hyperglycaemia, hyperphagia, polydipsia, polyuria, thirst. Horizon dosage: . During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PAXIL (View Paxil Review and Paxil Label ), SERMION (View Sermion Review and Sermion Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), INNOLET 30R (View Innolet 30r Review and Innolet 30r Label ). Patient was hospitalized.

4724964-1 | Hyperglycaemia
on Jul 15, 2005 Female patient from JAPAN , 68 years of age, was diagnosed with diabetes mellitus and was treated with Horizon (View Usage). Patient had the following side effects: hyperglycaemia. Horizon dosage: . During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PAXIL (View Paxil Review and Paxil Label ), SERMION (View Sermion Review and Sermion Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), INNOLET 30R (View Innolet 30r Review and Innolet 30r Label ). Patient was hospitalized.

4718182-0 | Atrial Fibrillation
Patient was taking Horizon (View Usage). After Horizon was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Jun 20, 2005 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with sedation, anaesthesia, hypertension, diabetes mellitus and. Horizon dosage: . During the same period patient was treated with NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ), SOSEGON (View Sosegon Review and Sosegon Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), NASAL OXYGEN (View Nasal Oxygen Review and Nasal Oxygen Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ), ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ).

4709931-6 | Anaesthetic Complication Neurological, Blood Pressure Decreased, Blood Pressure Systolic Decreased, Dyspnoea, Hypoglossal Nerve Disorder, Oxygen Saturation Decreased, Paralysis, Post Procedural Complication, Speech Disorder
Adverse event was reported on Jun 10, 2005 by a Male patient taking Horizon (View Usage) (Dosage: Taken 1 Hour And 30 Minutes Prior To Surgery.) was diagnosed with sedation and. Location: JAPAN , 58 years of age, weighting 191.8 lb, Patient experienced the following unwanted or unexpected effects: anaesthetic complication neurological, blood pressure decreased, blood pressure systolic decreased, dyspnoea, hypoglossal nerve disorder, oxygen saturation decreased, paralysis (What is paralysis?), post procedural complication, speech disorder. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), CARBOCAIN (View Carbocain Review and Carbocain Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ).

4696082-2 | Blood Pressure Systolic Decreased, Dyspnoea, Hypoglossal Nerve Disorder, Inadequate Analgesia, Medical Device Complication, Oxygen Saturation Decreased, Speech Disorder, Tongue Paralysis
on Jun 10, 2005 Male patient from , 58 years of age, weighting 191.8 lb, was treated with Horizon (View Usage). Patient had the following side effects: blood pressure systolic decreased, dyspnoea, hypoglossal nerve disorder, inadequate analgesia, medical device complication, oxygen saturation decreased, speech disorder, tongue paralysis. Horizon dosage: Taken 1 Hour And 30 Minutes Prior To Surgery.. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), PROPOFOL (Received 50 Minutes After Start Of Surgery) (View Propofol Review and Propofol Label ).

4656160-0 | Blood Creatine Phosphokinase Increased, Respiratory Depression
on Apr 28, 2005 Female patient from , 38 years of age, weighting 110.2 lb, was diagnosed with anaesthesia, diabetes mellitus and was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: blood creatine phosphokinase increased, respiratory depression. Horizon dosage: First Anaesthesia.. During the same period patient was treated with RANITIDINE HYDROCHLORIDE (Used During Both Surgeries.) (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), ATROPINE SULFATE (Used During Both Surgeries.) (View Atropine Sulfate Review and Atropine Sulfate Label ), DIET AID NOS (View Diet Aid Nos Review and Diet Aid Nos Label ), FENTANYL CITRATE (Used During Both Surgeries.) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PROPOFOL (Used During Both Surgeries.) (View Propofol Review and Propofol Label ), LIDOCAINE W/ EPINEPHRINE (View Lidocaine W/ Epinephrine Review and Lidocaine W/ Epinephrine Label ).

4654776-9 | Blood Glucose Increased, Encephalopathy, Status Epilepticus, Vomiting
Patient was taking Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, encephalopathy, status epilepticus, vomiting on Apr 26, 2005 from Additional patient health information: Female patient , child 3 years of age, was diagnosed with influenza and. Horizon dosage: . During the same period patient was treated with CEFZON (View Cefzon Review and Cefzon Label ), CALONAL (View Calonal Review and Calonal Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ).

4642462-0 | Cardiovascular Disorder, Cerebral Atrophy, Condition Aggravated, Convulsion, Encephalopathy, Mental Impairment
Adverse event was reported on Apr 13, 2005 by a Female patient taking Horizon (View Usage) (Dosage: ) was diagnosed with clonic convulsion and. Location: , child 4 years of age, Patient had the following side effects: cardiovascular disorder, cerebral atrophy, condition aggravated, convulsion, encephalopathy, mental impairment. During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

4623946-8 | Respiratory Depression
on Mar 17, 2005 Male patient from , 25 years of age, was diagnosed with convulsion and was treated with Horizon (View Usage). After Horizon was administered, patient had the following side effects: respiratory depression. Horizon dosage: . During the same period patient was treated with REPTILASE S (View Reptilase-s Review and Reptilase-s Label ).

4614031-X | Respiratory Depression
on Mar 17, 2005 Male patient from , 25 years of age, was treated with Horizon (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory depression. Horizon dosage: . During the same period patient was treated with REPTILASE (View Reptilase Review and Reptilase Label ).

4611547-7 | Blood Amylase Increased, Body Temperature Increased, Hepatic Enzyme Increased, Serotonin Syndrome
Patient was taking Horizon (View Usage). Patient had the following side effects: blood amylase increased, body temperature increased, hepatic enzyme increased, serotonin syndrome on Mar 08, 2005 from Additional patient health information: Female patient , 27 years of age, was diagnosed with status epilepticus and. Horizon dosage: . During the same period patient was treated with DORMICUM (INJ) (View Dormicum (inj) Review and Dormicum (inj) Label ), AMOXAN (View Amoxan Review and Amoxan Label ), BARBITURATE (View Barbiturate Review and Barbiturate Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).